Financial results - CADOMEDICA 93 SRL

Financial Summary - Cadomedica 93 Srl
Unique identification code: 4762379
Registration number: J10/1665/1993
Nace: 8622
Sales - Ron
116.638
Net Profit - Ron
84.320
Employee
5
The most important financial indicators for the company Cadomedica 93 Srl - Unique Identification Number 4762379: sales in 2023 was 116.638 euro, registering a net profit of 84.320 euro and having an average number of 5 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Cadomedica 93 Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 60.075 75.478 88.452 85.432 151.980 187.835 151.632 165.602 144.064 116.638
Total Income - EUR 60.075 75.478 88.452 85.432 152.227 187.835 161.976 165.602 144.064 116.638
Total Expenses - EUR 24.036 18.093 19.059 20.350 25.081 25.904 21.951 20.551 27.994 31.152
Gross Profit/Loss - EUR 36.040 57.385 69.393 65.081 127.146 161.930 140.025 145.051 116.069 85.486
Net Profit/Loss - EUR 34.237 55.121 68.508 64.227 125.624 160.052 138.405 143.410 114.628 84.320
Employees 5 5 5 5 5 5 5 5 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -18.8%, from 144.064 euro in the year 2022, to 116.638 euro in 2023. The Net Profit decreased by -29.961 euro, from 114.628 euro in 2022, to 84.320 in the last year.

Check the financial reports for the company - Cadomedica 93 Srl

Rating financiar

Financial Rating -
Cadomedica 93 Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Cadomedica 93 Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cadomedica 93 Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Cadomedica 93 Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cadomedica 93 Srl - CUI 4762379

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 0 0 0 0 0 4.581
Current Assets 63.444 113.697 181.342 239.809 358.327 508.439 205.793 216.515 116.203 85.766
Inventories 346 482 498 383 249 244 0 0 0 0
Receivables 35 35 0 0 21 20 1.970 3.719 89.379 52.817
Cash 63.063 113.179 180.844 239.427 358.057 508.174 203.822 212.797 26.824 32.949
Shareholders Funds 34.360 55.245 68.631 64.348 125.742 160.168 138.519 143.521 114.740 84.431
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 29.084 58.452 112.711 175.462 232.585 348.271 67.273 72.994 1.463 5.916
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 85.766 euro in 2023 which includes Inventories of 0 euro, Receivables of 52.817 euro and cash availability of 32.949 euro.
The company's Equity was valued at 84.431 euro, while total Liabilities amounted to 5.916 euro. Equity decreased by -29.961 euro, from 114.740 euro in 2022, to 84.431 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Cadomedica 93 Srl

Comments - Cadomedica 93 Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.